Prosecution Insights
Last updated: October 02, 2026

Examiner: POHNERT, STEVEN C

Tech Center 1600 • Art Units: 1634 1655 1683

This examiner grants 12% of resolved cases

Analysis

Steven C. Pohnert is an examiner in Tech Center 1600 and Art Unit 1634. The examiner has a low allowance rate of 12.4 percent across 871 resolved cases. This suggests a very rigorous examination environment. The median days to allowance is 1534, indicating that the path to a grant is both difficult and time-consuming. With 871 resolved cases, the data shows a consistent pattern of low allowance and long pendency.

The interview lift for this examiner is 18.5 percent. This is a significant figure when compared to the baseline allowance rate of 12.4 percent. Practitioners should prioritize interviews, as the 18.5 percent lift represents a substantial improvement in the likelihood of success. Despite the 1534 median days to allowance, the interview remains a key tool for navigating Art Unit 1634. The 871 resolved cases confirm that while the 12.4 percent allowance rate is low, the 18.5 percent interview lift offers a measurable advantage for applicants.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

12.4%
Allow Rate
-47.6% vs TC avg
972
Total Applications
+18.5%
Interview Lift
1534
Avg Prosecution Days
Based on 871 resolved cases, 2023–2026

Rejection Statute Breakdown

14.3%
§101 Eligibility
9.5%
§102 Novelty
31.7%
§103 Obviousness
35.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18257233 Determining the Quantity and Quality of a DNA Library Non-Final OA Robert Bosch GmbH
17757132 Method for Carrying Out an Amplification Reaction in a Microfluidic Apparatus Final Rejection Robert Bosch GmbH
18503949 IMMOBILIZATION METHODS AND COMPOSITIONS FOR IN SITU DETECTION Non-Final OA 10x Genomics, Inc.
18343108 METHODS AND SYSTEMS FOR LIGHT-CONTROLLED SURFACE PATTERNING USING PHOTOMASKS Non-Final OA 10x Genomics, Inc.
18120024 CONCATEMERIC DETECTABLE PROBES AND RELATED METHODS Non-Final OA 10x Genomics, Inc.
18209992 COMPOSITIONS AND METHODS OF RNA ANALYSIS Final Rejection The Johns Hopkins University
17845487 METHODS FOR ASSESSING RATES OF DNA REPAIR Final Rejection The Johns Hopkins University
18844272 MULTIPLEX FLUORESCENT CELLULAR AND TISSUE IMAGING WITH DNA ENCODED THERMAL CHANNELS AND USES THEREOF Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
18410439 MULTIPLEXED IMAGING USING MERFISH, EXPANSION MICROSCOPY, AND RELATED TECHNOLOGIES Non-Final OA President and Fellows of Harvard College
18310477 MATRIX IMPRINTING AND CLEARING Final Rejection President and Fellows of Harvard College
17289889 NUCLEIC ACID-BASED BARCODING Final Rejection PRESIDENT AND FELLOWS OF HARVARD COLLEGE
18192147 METHOD FOR PRODUCING COMPLEX, METHOD FOR DETERMINING MICROBIAL INCLUSION, AND METHOD FOR IDENTIFYING INCLUDED MICROORGANISM Non-Final OA Yokogawa Electric Corporation
17147151 METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18021625 PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF Final Rejection The General Hospital Corporation
17513640 PREDICTING BREAST CANCER RECURRENCE Non-Final OA The General Hospital Corporation
18517623 Non-Small Cell Lung Cancer Diagnosis and Treatment Non-Final OA West Virginia University Board of Governors on Behalf of West Virginia University
17282650 TARGET NUCLEIC ACID DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION Final Rejection AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18267701 IGH REARRANGEMENTS AND USES THEREOF Non-Final OA Foundation Medicine, Inc.
17802436 MITIGATION OF STATISTICAL BIAS IN GENETIC SAMPLING Final Rejection Foundation Medicine, Inc.
18758066 PROTECTING FULLY FUNCTIONAL NUCLEOTIDES FROM DEGRADATION Non-Final OA Illumina, Inc.
18507414 DESIGNING PROBES FOR DEPLETING ABUNDANT TRANSCRIPTS Non-Final OA Illumina, Inc.
18476151 NUCLEIC ACID SEQUENCING COMPONENTS INCLUDING A GLYCOLIPID BI-LAYER Non-Final OA ILLUMINA, INC.
18476031 MESOPHILIC COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION Non-Final OA Illumina, Inc.
17472038 COMPOSITIONS AND METHODS FOR DETECTING AN ABASIC SITE Non-Final OA ILLUMINA, INC.
18689062 METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE Non-Final OA MGI TECH CO., LTD.
18065952 LARGE-SCALE SYNTHESIS OF MESSENGER RNA Final Rejection Translate Bio, Inc.
17333569 METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS Final Rejection Sequenom, Inc.
18033857 MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC Non-Final OA YYZ PHARMATECH INC.
18153617 COMBINATION DISPLACEMENT PROBES Non-Final OA Detect, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month